Selected clotting factors in blood of patients with abdominal aortic aneurysms

Kardiologia Polska

Volumn 70, Issue 6, 2012, Pages 574-579

  Kotschy, Maria ^a   Witkiewicz, Wojciech ^a   Grendziak, Ryszard ^a   Dubis, Joanna ^a   Zapotoczny, Norbert ^a   Kotschy, Daniel ^a  

^a Regional Specialised Hospital in Wroclaw   (Poland)

Author keywords

Abdominal aortic aneurysms; TAT complexes; TF; TFPI; VEGF A

Indexed keywords

THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN A;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL;

EID: 84863758479     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. White JW, Haas K, Phillips S, Comeruta AJ. Adventitionalelastolysis is a primary event in aneurysm formation. J VascSurg, 1993; 17: 371-380.
2. Dobrin PB, Markvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg, 1994; 2: 484-488. (Pubitemid 24244754)
3. Gacko M. Metaloproteinazy macierzy miȩdzykomórkowej. Post Hig Med. Dośw, 1997; 51: 577-589.
4. Wassef M, Baxter BT, Chisholm RL et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung and Blood Institute. J Vasc Surg, 2001; 34: 730-738. (Pubitemid 33664926)
5. Ailawadi G, Eliason JL, Upchurch GR, Mich AH. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg, 2003; 38: 584-588. (Pubitemid 41123227)
6. Reilly JM. Plasminogen activators in abdominal aortic aneurysm disease. Ann NY Acad Sci, 1996; 800: 151-156. (Pubitemid 27028952)
7. Gacko M. Tkankowy i osoczowy układ hemostatyczny w tȩtniaku aorty. Postȩpy Nauk Med, 2001; 2: 30-38.
8. Carmeliet P, Moons L, Lijnen R. Urokinase generated plasmin activates matrix metalloproteinasesduring aneurysm formation. Nat Genet, 1997; 17: 439-444. (Pubitemid 27518393)
9. Gacko M, Głowiński S. Activities of proteases in parietal thrombus of aortic aneurysm. Clin Chim Acta, 1998; 271: 171-177. (Pubitemid 28135215)
10. Carrell TWG, Burnand KG, Booth NA. Intraluminal thrombus enhances proteolysis in abdominal aortic aneurysms. Vascular, 2006; 14: 1-8.
11. Cnotliwy M, Jastrzȩbska M, Wienicki I, Chełstowski K. Coagulation and fibrinolysis in the abluminal layer of the thrombus within abdominal aortic aneurysm. Acta Angiol, 2007; 13: 114-121. (Pubitemid 350219423)
12. Steffel J, Thomas F, Lüscher MD, Felix C, Tanner MD. Tissue factor in cardiovascular diseases. Circulation, 2006; 113: 73-75.
13. Kotschy M, Kotschy D, Witkiewicz W. Rola czynnika tkankowego w procesie krzepniȩcia krwi oraz w powikłaniach zakrzepowych. Kardiol Pol, 2010; 68: 1158-1162.
14. Migdalski A, Jawień A, Kotschy M, Knapik-Bieniek A. Selected haemostatic factors in carotid bifurcation plaque of patients undergoing carotid endarterectomy. Eur J Vasc Endovasc Surg, 2004; 27: 172-177.
15. Migdalski M, Kotschy M, Jawień A. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg, 2005; 30: 41-47. (Pubitemid 40775131)
16. Ferrara N. Vascular endothelial growth factor. basic science and clinical progress. Endocrine Rev, 2004; 25: 581-611. (Pubitemid 39099316)
17. Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost, 2002; 86: 959-972.
18. Radziwon P, Bielawiec M, Kłoczko J et al. Tissue factor pathway inhibitor (TFPI) in patients with occlusive arterial diseases in consideration with risk factors and conservative treatment of the diseases. Angiology, 2001; 7: 43-54.
19. Ross R. The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature, 2003; 362: 801-809.
20. Hobbs SD, Haggart P, Fegan C, Bradbury AW, Adam DJ. The role of tissue factor undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms. J Vasc Surg, 2007; 46: 682-686. (Pubitemid 47446120)
21. Jeleńska MM, Szmidt J, Bojakowski K, Grzela T, Palester-Chlebowczyk M. Compensated activation of coagulation in patients with abdominal aortic aneurysm: effects of heparin treatment to elective surgery. Thromb Haemost, 2004; 92: 997-1002. (Pubitemid 39545522)
22. Adam DJ, Haggart PC, Ludlam CA, Bradbury AW. Haemostatic markers before operation in patients with acutely symptomatic nonruptured and ruptured infrarenal abdominal aortic aneurysms. J Vasc Surg, 2002; 35: 661-665.
23. Skagius E, Siegbahn A, Berggvist D, Henricsson AE. Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock. J Thromb Haemost, 2008; 1: 147-150.